| Date Checked | 2025-12-21 23:36:33 |
|---|---|
| Graham Number | (PB)nan vs (PE)0.00 |
| Over / Under Value Percentage | 0.00% vs 0.00% |
| Dividend Yield | 0.00% |
| Dividend Date | None |
| Symbol | OPK |
| AssetType | Common Stock |
| Name | Opko Health Inc |
| Description | Opko Health, Inc. is a diversified healthcare company headquartered in Miami, Florida, specializing in the development and commercialization of innovative pharmaceuticals and diagnostic products in urology, endocrinology, and infectious diseases. With a robust presence in the United States, Ireland, and Spain, Opko leverages proprietary technologies and strategic collaborations to address unmet medical needs and enhance patient outcomes. The company's commitment to continuous innovation and expansion of its product portfolio positions it as a significant player in the global healthcare market, dedicated to improving patient care through advanced therapeutic solutions. |
| CIK | 944809 |
| Exchange | NASDAQ |
| Currency | USD |
| Country | USA |
| Sector | HEALTHCARE |
| Industry | DIAGNOSTICS & RESEARCH |
| Address | 4400 BISCAYNE BOULEVARD, MIAMI, FL, UNITED STATES, 33137 |
| OfficialSite | https://www.opko.com |
| FiscalYearEnd | December |
| LatestQuarter | 2025-09-30 |
| MarketCapitalization | 1095420000 |
| EBITDA | -115814000 |
| PERatio | 0 |
| PEGRatio | -2.87 |
| BookValue | 1.698 |
| DividendPerShare | None |
| EPS | -0.24 |
| RevenuePerShareTTM | 0.881 |
| ProfitMargin | -0.281 |
| OperatingMarginTTM | -0.353 |
| ReturnOnAssetsTTM | -0.0615 |
| ReturnOnEquityTTM | -0.133 |
| RevenueTTM | 642067000 |
| GrossProfitTTM | 121546000 |
| DilutedEPSTTM | -0.24 |
| QuarterlyEarningsGrowthYOY | -0.126 |
| QuarterlyRevenueGrowthYOY | -0.126 |
| AnalystTargetPrice | 3.558 |
| AnalystRatingStrongBuy | 3 |
| AnalystRatingBuy | 2 |
| AnalystRatingHold | 1 |
| AnalystRatingSell | 0 |
| AnalystRatingStrongSell | 0 |
| TrailingPE | - |
| ForwardPE | 64.52 |
| PriceToSalesRatioTTM | 1.706 |
| PriceToBookRatio | 0.811 |
| EVToRevenue | 1.619 |
| EVToEBITDA | 23.0 |
| Beta | 1.342 |
| 52WeekHigh | 2.035 |
| 52WeekLow | 1.11 |
| 50DayMovingAverage | 1.409 |
| 200DayMovingAverage | 1.429 |
| SharesOutstanding | 767701000 |
| SharesFloat | 347991000 |
| PercentInsiders | 48.708 |
| PercentInstitutions | 26.136 |
| ExDividendDate | None |
| naga | 0 |
| etoro | 0 |
| dateChecked | 2025-12-21 23:36:33 |
| fresh | 1 |